Explore more publications!

Jordan Technology Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jordan Technology Report.

December 2025

January 2026

February 2026

Press releases published on February 9, 2026

وزارة المواصلات تستضيف النسخة الثانية من المنتدى الدولي للنقل الكهربائي والتنقل ذاتي القيادة أبريل القادم

2 hours ago

وزارة المواصلات تستضيف النسخة الثانية من المنتدى الدولي للنقل الكهربائي والتنقل ذاتي القيادة أبريل القادم

EIN Presswire

Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology

37 minutes ago

Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology

GlobeNewswire

Gute Verkaufszahlen für Cresemba® (Isavuconazol) in der Region Asien-Pazifik und China lösen Meilensteinzahlung an Basilea aus

an hour ago

Gute Verkaufszahlen für Cresemba® (Isavuconazol) in der Region Asien-Pazifik und China lösen Meilensteinzahlung an Basilea aus

GlobeNewswire

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea

an hour ago

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea

GlobeNewswire

Communiqué de presse: Le rilzabrutinib de Sanofi a été désigné comme thérapie innovante aux États-Unis et comme médicament orphelin au Japon pour le traitement de l’anémie hémolytique auto-immune à anticorps chauds

2 hours ago

Communiqué de presse: Le rilzabrutinib de Sanofi a été désigné comme thérapie innovante aux États-Unis et comme médicament orphelin au Japon pour le traitement de l’anémie hémolytique auto-immune à anticorps chauds

GlobeNewswire

Press Release: Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia

2 hours ago

Press Release: Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia

GlobeNewswire

WISeKey’s WISe.Art and GMA Once Again Revolutionize the Future of Art and Technology in an Extraordinary Event in Venice

2 hours ago

WISeKey’s WISe.Art and GMA Once Again Revolutionize the Future of Art and Technology in an Extraordinary Event in Venice

GlobeNewswire

InnoCare Announces IND Approval to Initiate Clinical Trial of VAV1 Degrader ICP-538 in China

5 hours ago

InnoCare Announces IND Approval to Initiate Clinical Trial of VAV1 Degrader ICP-538 in China

GlobeNewswire

Digital Realty Debuts NVIDIA Certification for Liquid Cooled Data Center in Japan

6 hours ago

Digital Realty Debuts NVIDIA Certification for Liquid Cooled Data Center in Japan

GlobeNewswire

Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China

6 hours ago

Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China

GlobeNewswire